Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnly, openWorld, idempotent), the description reveals key behaviors: company data comes from LATEST 10-K via SEC EDGAR/XBRL, off-calendar fiscal years handled correctly, results sorted by primary metric, and returns paired data with citation URIs. This exceeds annotation coverage.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is well-structured: begins with usage examples, then key advice, then data sources per type, then output details. It is somewhat lengthy but each sentence adds value. Could trim minor redundancy but overall efficient.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description adequately describes return format (paired data + citation URIs) and behavior (sorted results). It covers both entity types thoroughly, including data sources and fiscal year handling. No gaps remain for an agent to understand what the tool does and returns.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions for both parameters. The description adds value by elaborating on the 'values' parameter: for company it specifies tickers/CIKs, for drug names, and mentions max 5 and min 2. It also explains how results are sorted, which is not in the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it performs side-by-side comparison of 2-5 companies or drugs, with specific invocation examples like 'X vs Y' and 'rank these companies'. It distinguishes from siblings like entity_profile (single entity) and search_within by emphasizing efficiency over sequential lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly instructs 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', which strongly guides when to use. However, it does not explicitly mention when not to use (e.g., for single entity lookups), though that is implied by the comparison focus.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

Several tools have blurry boundaries: ask_pipeworx and ask_pipeworx_beta are explicitly identical right now, polymarket_edges/polymarket_arbitrage/polymarket_edge_tracker/polymarket_fill_risk all target overlapping prediction-market signals, and ai_visibility_check vs scan_competitor_ai_presence plus entity_profile vs recent_changes vs compare_entities partially duplicate each other. The Webflow tools are distinct, but the dominant Pipeworx cluster is hard to navigate.

Naming Consistency2/5

Naming mixes multiple conventions: clean verb_noun for Webflow tools (list_sites, get_collection_item), an ask_pipeworx family, plain single verbs (remember, recall, forget), and long noun-cluster names for prediction markets (polymarket_arbitrage, polymarket_edge_tracker). There is no single predictable pattern across the set.

Tool Count1/5

36 tools is excessive for a server named 'Webflow' — only about six tools actually concern the Webflow CMS (list_sites, get_site, list_collections, list_collection_items, get_collection_item, generate_llms_txt). The remaining ~30 tools form a completely different data-research/prediction-market/memory suite, making the server wildly over-scoped and mislabeled.

Completeness2/5

For the Webflow domain, the surface is read-only: sites and collections can be listed and items fetched, but there are no create, update, delete, or publish operations, leaving obvious lifecycle gaps. The extensive non-Webflow tools do not address the stated server purpose, so the mismatch hurts completeness rather than fixing it.